Catalyst
Slingshot members are tracking this event:
KalVista's (KALV) KVD900 in Hereditary Angioedema (HAE) Phase 2 data due 1Q 2021
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KALV | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 09, 2021
Occurred Source:
https://ir.kalvista.com/news-releases/news-release-details/kalvista-pharmaceuticals-reports-positive-results-kvd900-phase-2
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Kvd900, Phase 2 Top-line Data, Hereditary Angioedema
